PO-0654: Hypofractionated StereotaticRS for patients with brain metastases. Outcome evaluation and toxicity. (April 2016) - Navarria, P.; Ascolese, A.; D'agostino, G.; Villa, E.; Clerici, E.; Tozzi, A.; Iftode, C.; De Rose, F.; Liardo, L.; Comito, T.; Franzese, C.; Franceschini, D.; et al.